I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I-Mab
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Long-Term Investments
ÂĄ12.1m
CAGR 3-Years
-74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Long-Term Investments
ÂĄ635.2m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Long-Term Investments
ÂĄ1.4B
CAGR 3-Years
89%
CAGR 5-Years
126%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Long-Term Investments
ÂĄ17B
CAGR 3-Years
8%
CAGR 5-Years
117%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Long-Term Investments
ÂĄ295.2m
CAGR 3-Years
8%
CAGR 5-Years
27%
CAGR 10-Years
77%
Imeik Technology Development Co Ltd
SZSE:300896
Long-Term Investments
ÂĄ1.9B
CAGR 3-Years
216%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is I-Mab's Long-Term Investments?
Long-Term Investments
12.1m CNY

Based on the financial report for Dec 31, 2023, I-Mab's Long-Term Investments amounts to 12.1m CNY.

What is I-Mab's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-74%

Over the last year, the Long-Term Investments growth was -61%. The average annual Long-Term Investments growth rates for I-Mab have been -74% over the past three years .

Back to Top